These findings suggested that inhibiting NOX4 enhanced the protective effects of rIPC on renal function and tubular injury, suggesting the synergistic effect of NOX4 inhibition and rIPC in treating AKI. The gene discussed is NOX4; the disease is acute kidney injury.